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Teaghrelins are unique acylated flavonoid tetraglycosides found in Chin-shin oolong tea,
and have been demonstrated to be promising oral ghrelin analogues. The biosynthetic
pathway of teaghrelins from quercetin-3-O-rutinoside (rutin) or kaempferol-3-O-rutinoside
(nicotiflorin) was proposed to comprise three enzymatic steps according to the identifi-
cation of putative intermediates in Chin-shin oolong tea. In addition to the two known
teaghrelins in Chin-shin oolong tea, four teaghrelin-like compounds with different at-
tachments of glycosides were identified in various oolong teas. Molecular modeling and
docking were used to evaluate theoretically whether the putative biosynthetic in-
termediates of teaghrelins and the four teaghrelin-like compounds could be potential
candidates of ghrelin analogues. The results showed that the attachment of a coumaroyl
group was crucial for these tea compounds to bind to the ghrelin receptor. However, the
additional attachment of a rhamnosyl glycoside to the flavonoid backbone of teaghrelin-
like compounds at C-7 significantly reduced their binding affinity with the ghrelin receptor.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.
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Ghrelin is a peptide hormone consisting of 28 amino acids, in
which the third serine residue is acylated with an n-octanoyl
group essential for its biological functions [1e3]. It iste of Biotechnology, Natio
.-y. Chung), tctzen@drag
s study.
ministration, Taiwan. Publcolloquially called the “hunger hormone”, and its target re-
ceptor is a G protein-coupled receptor also known as the
growth hormone secretagogue-1a receptor [1,4]. The remark-
able physiological functions of ghrelin via activation of the
ghrelin receptor are promotion of appetite by stimulation ofnal Chung Hsing University, Taiwan
on.nchu.edu.tw (J.T.C. Tzen).
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 6 6 0e6 7 0 661hypothalamic arcuate nucleus and induction of growth hor-
mone release from the anterior pituitary gland [5,6]. In addi-
tion, several other biological effects of ghrelin have been
reported, including influence on the reproductive system, the
gastrointestinal system, glucose metabolism, and cardiovas-
cular functions [7e9]. On the basis of the multiple biological
activities of ghrelin, both peptidyl and nonpeptidyl ghrelin
analogues were synthesized and aimed to develop potential
therapeutic applications of several diseases, e.g., gastroin-
testinal deficiency and anorexia [10e13]. Unfortunately, no
synthetic oral ghrelin analogues were satisfactory and
approved for clinical application thus far.
Tea is one of the most widely consumed beverages around
the world [14], and its major ingredients, flavonols and poly-
phenols, have been demonstrated to provide a variety of
health benefits [15e17]. According to the degree of fermenta-
tion in preparation, teas are mainly classified as green tea
(unfermented), oolong tea (semifermented), and black tea
(fully fermented), where the term fermentation refers to nat-
ural browning reactions induced by oxidative enzymes in the
cells of tea leaves [18]. Over the past few decades, oolong tea
has been the most favorite choice of Taiwanese because of its
special taste and flavor [19,20].
Teaghrelins are unique acylated flavonoid tetraglycosides
found in Chin-shin oolong tea, and have been demonstrated
to be responsible for the hunger induction just as the endog-
enous hunger hormone, ghrelin [21,22]. Similar to ghrelin,
teaghrelins are able to induce hunger sensation of rats as well
as stimulate growth hormone secretion of rat primary anterior
pituitary cells [21]. According to the observation in the afore-
mentioned animal study and cell line assay, teaghrelins were
proposed to be promising oral ghrelin analogues, provided
they undergo necessary clinical trials.
In addition to teaghrelins, some flavonoid derivatives were
also found in Chin-shin oolong tea [23]. Presumably, these
flavonoid derivatives might serve as intermediates in the
biosynthetic pathway of teaghrelins. Moreover, several
teaghrelin-like compounds, acylated flavonoid tetraglyco-
sides with different attachments of glycosides, were detected
in various oolong teas [24]. In this study, we aimed to search
for more potential oral ghrelin analogues by screening flavo-
noid derivatives in Taiwan oolong teas. We first identified the
putative biosynthetic intermediates of teaghrelins in Chin-
shin oolong tea and teaghrelin-like compounds in various
oolong teas. To evaluate the possibility if the putative
biosynthetic intermediates of teaghrelins and the teaghrelin-
like compounds could be potential candidates of ghrelin an-
alogues, molecular modeling of these compounds docking to
the ghrelin receptor was exhibited.2. Methods
2.1. Chemicals and materials
All chemicals were purchased from E. Merck Co. (Merck KGaA,
Darmstadt, Germany) unless stated otherwise. High-
performance liquid chromatography (HPLC) grade acetoni-
trile was purchased from Fisher Scientific (Fair Lawn, NJ, USA).
Acetic acid (99.7%) was obtained from J.T. Baker (MallinckrodtBaker, Inc., Phillipsburg, NJ, USA). Rutin was purchased from
Sigma Co. (Sigma-Aldrich, St. Louis, MO, USA). Purified water
was afforded by a Millipore clear water purification system
(Direct-Q, Millipore, Billerica, MA, USA). Various oolong teas
prepared from tea plants (Camellia sinensis L.), including
Alishan Chin-shin, Dongding Chin-shin, Wuyi, Baihao, and
Tieguanyin, were gifts or purchased from local tea producers.
Teaghrelins were purified from Chin-shin oolong teas ac-
cording to the protocol as described previously [22].
2.2. Preparation and HPLC analysis of tea infusions
Tea infusions were prepared by adding 20 mL of boiling water
to 1 g of various oolong teas for 10 minutes. After cooling to
room temperature, the brew was filtered through a 0.22 mm
polyvinylidene difluoride (PVDF) membrane filter (Pall Cor-
poration, Glen Cove, NY, USA) for the following analysis.
Chemical constituents in oolong tea infusions were analyzed
by HPLC system coupled to a 600E photodiode array detector
(Waters Corporation, Milford, MA, USA), and separation was
performed on the Syncronis C18 column (4.6  250 mm inner
diameter, 5 mm, Thermo Scientific, Waltham, MA, USA). The
separated condition of HPLC analysis was prepared according
to Lo et al [21]. The mobile phase consisted of (A) water con-
taining 0.5% acetic acid and (B) acetonitrile. The gradient was
as follows: 060 minutes, linearly gradient from 10% to 30% B;
6170 minutes 30% B; and 71100 min, linearly gradient from
30% to 10% B. The column was maintained at room temper-
ature and the injection volumewas 10 mL at a flow rate of 1mL/
min. The ultraviolet (UV) absorbance detection wavelength
was set at 280 nm.
2.3. Mass spectrometric analysis
Mass spectrometric analysis was performed on a LTQ (linear
trap quadrupole) tandem mass spectrometer (Thermo Elec-
tron, San Jose, CA, USA) equipped with an electrospray ioni-
zation (ESI) interface and connected to a Surveyor LC system
(Thermo Electron, San Jose, CA, USA) with a 5 mL sample loop.
The analytes were separated with the same condition of HPLC
analysis. The flow rate was 1 mL/min. The mass spectra were
obtained with negative ESI mode. The heated capillary tem-
perature was 300C, and the spray voltage was 4.5 kV. Flow
rates of sheath gas, auxiliary gas, and sweep gas were 50, 13,
and 3 arbitrary units, respectively. Data-dependent acquisi-
tion (DDA) was used to perform under automatic gain control
conditions. The first scanwas operated in full-scanmodewith
m/z values ranging from 150 to 1500. The other scans were set
as the data-dependent MSn scan using the high-purity helium
(>99.99%) as the collision gas and the relative collision energy
of 3335%. The flavonoid derivatives shown in the HPLC
profiles were identified according to the same procedure as
described previously [23].
2.4. Homology modeling of three-dimensional structure
of human ghrelin receptor
The protein sequence of a human ghrelin receptor (growth
hormone secretagogue receptor, Genbank accession number
AAI13548) was uploaded to the SWISS-MODEL website (http://
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 6 6 0e6 7 0662swissmodel.expasy.org/interactive#sequence) to search for
proper templates for modeling [25]. Crystal structures of b1
and b2 adrenergic receptors (PDB 2YCY and 3PDS) with bound
ligands, cyanopindolol, and FAUC50, were used to construct
the human ghrelin receptor structure by homology modeling
[26,27]. The two ligands were removed in the modeling
structure first, and the loop region (H186-L210) was further
refined by employing the Loop Refinement (MODELER)module
under the disulfide bond set betweenC116 and C198 [28,29]. To
assist the following ligand docking, the protrusive flexible
loop (V184-N196) on the surface of the modeling ghrelin re-
ceptor structure was removed. The modeling structure with
the lowest probability density function (PDF) total energy was
selected for docking with a synthetic analogue of ghrelin,
growth hormone-releasing hexapeptide-6 (GHRP-6), and the
flavonoid derivatives identified in oolong teas. All the
modeling processes were performed by using Discovery Stu-
dio 2.1 platform (http://accelrys.com/).2.5. Molecular modeling and docking
The three-dimensional (3D) structures of GHRP-6 and rutin
were downloaded from the PubChem compound database in
the National Center for Biotechnology Information (NCBI)
website (http://www.ncbi.nlm.nih.gov/). The 3D structures of
the flavonoid derivatives identified in oolong teas were built
based on the structure of rutin by using the Chem3D program
(http://www.cambridgesoft.com/). The binding pocket for the
ligand molecules was defined as the cavity among the extra-
cellular loops linking transmembrane segments of IIIeVII in
the modeling ghrelin receptor structure [30]. In the docking
simulation, the ligand-binding site of the ghrelin receptor was
defined as the spherical space with a 14 A˚ radius from the
center of the binding pocket. Docking of GHRP-6 or tea flavo-
noid derivatives to the binding site of the ghrelin receptor was
performed in silico by employing the LibDock module in the
Discover Studio 2.1 package, and further minimized by smartAU
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Fig. 1 e High-performance liquid chromatography profiles of Ch
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identified compounds are shown in Table 1. Caffeine and the mminimize algorithm with CHARMm force field in the Discover
Studio 2.1 package [31,32]. To compare the binding affinity
between GHRP-6 and tea flavonoid derivatives, the intermo-
lecular molecular interactions, H-bonding, charge-charge,
cation-p interaction, and p-p interaction were further
analyzed in the docking complex structures of the ghrelin
receptor bound with ligands.3. Results
3.1. Identification of flavonoid derivatives in Chin-shin
oolong tea
To identify putative intermediates in the biosynthetic
pathway of teaghrelins, flavonoid derivatives that were
structurally related to teaghrelins were examined in Chin-
shin oolong tea. The result showed that six candidate flavo-
noid derivatives (Compounds 1 to 6) were detected besides the
two known teaghrelins (Compounds 7 and 8) (Figure 1). In
comparison with three reference compounds (rutin and two
teaghrelins) as well as the retention times of HPLC/UV profiles
and Mass data published previously [22], the six candidate
compounds were identified as quercetin-3-O-rutinoside
(rutin), kaempferol-3-O-rutinoside (nicotiflorin), quercetin-3-
O-glucosyl-rhamnosyl-glucoside, kaempferol-3-O-glucosyl-
rhamnosyl-glucoside, quercetin-3-O-glucosyl-rhamnosyl-(p-
coumaroyl) glucoside, and kaempferol-3-O-glucosyl-rhamno-
syl-(p-coumaroyl) glucoside (Table 1).
3.2. Putative biosynthetic pathway of teaghrelins
On the basis of the presence of the six flavonoid derivatives in
Chin-shin oolong tea, the biosynthetic pathway of teaghrelins
was putatively proposed to comprise three enzymatic steps
with rutin or nicotiflorin as the precursor molecule (Figure 2).
In the first step, a glucosemoleculewas added to the rhamosylutes
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Table 1 e Putative biosynthetic intermediates of teaghrelins identified in Chin-shin oolong tea, and teaghrelin-like
compounds identified in various oolong teas. The chromatographic profiles of these compounds are shown in Figure 1 and
Figure 3.
Peak no. Rt (min) [MeH]e
(m/z)
MS/MS (m/z) Compounds
1 59.95 609 301 Quercetin-3-O-rutinoside (Rutin)
2 67.49 593 447, 285 Kaempferol-3-O-rutinoside (nicotiflorin)
3 56.63 771 609, 463, 301 Quercetin-3-O-glucosyl-rhamnosyl-glucoside
4 63.54 755 593, 447, 285 Kaempferol-3-O-glucosyl-rhamnosyl-glucoside
5 87.32 917 771, 753, 301 Quercetin-3-O-glucosyl-rhamnosyl-(p-coumaroyl) glucoside
6 93.40 901 755, 737, 285 Kaempferol-3-O-glucosyl-rhamnosyl-(p-coumaroyl) glucoside
7 83.95 1079 933, 915, 301 Quercetin-3-O-glucosyl-rhamnosyl-(p-coumaroyl- glucosyl) glucose
(Teaghrelin-1)
8 89.14 1063 917, 899, 777, 285 Kaempferol-3-O-glucosyl-rhamnosyl-(p-coumaroyl-glucoosyl) glucoside
(Teaghrelin-2)
9 87.87 1049 917, 903, 887, 885, 747 Quercetin-3-O-glucosyl-rhamnosyl-(p-coumaroyl- arabinosyl) glucoside
10 92.52 1033 901, 887, 871, 869, 747 Kaempferol-3-O-glucosyl-rhamnosyl-(p-coumaroyl-arabinosyl) glucoside
11 86.43 1063 917 Quercetin-3-O-glucosyl-rhamnosyl-(p-coumaroyl) glucose-7-O-
rhamnoside
12 88.84 1047 901 Kaempferol-3-O-glucosyl-rhamnosyl-(p-coumaroyl) glucose-7-O-
rhamnoside
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 6 6 0e6 7 0 663group of rutin or nicotiflorin, and the elongation of rutinoside
(diglycoside) led to the formation of flavonoid triglycoside
(Compound 3 or 4). In the second step, p-coumaric acid was
acylated with the initial glucose directly linked to the oxygenglucose
glucos
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(Compounds 7 and 8) were consequently formed from rutin
and nicotiflorin, respectively.
3.3. Identification of teaghrelin-like compounds in
various oolong teas
To search for more teaghrelin-like compounds, acylated
flavonoid derivatives were screened in various Taiwan oolong
teas. The results showed that in addition to the two known
teaghrelins in Chin-shin oolong tea, four candidate
teaghrelin-like compounds were identified in various oolong
teas (Figure 3). Chin-shin oolong teas obtained from Alishan
and Dongding contained the same two teaghrelins (Com-
pounds 7 and 8), Wuyi oolong tea contained two teaghrelin-
like compounds (Compounds 9 and 10), and both Baihao
oolong tea and Tieguanyin contained another two teaghrelin-
like compounds (Compounds 11 and 12). Detailed analyses by
mass data (Table 1) showed that Compounds 9 and 10 differed
from teaghrelins by replacing the last attachment of glucose
(in the third enzymatic step of Figure 2) with arabinose
(Figure 4). In contrast with teaghrelins, Compounds 11 and 12
did not contain the last attachment of glucose (R1 position in
Figure 4); instead, they contained an extra attachment of
rhamnose at C-7 of the flavonoid backbone (R2 position in
Figure 4).
3.4. Docking of GHRP-6 and teaghrelins into the ghrelin
receptor
GHRP-6, a synthetic analogue of ghrelin, was selected as a
positive control for themolecularmodeling and docking to the
binding pocket of the ghrelin receptor (Figures 5Ae5D). As7:
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Fig. 4 e Structures of teaghrelins and teaghrelin-like
compounds identified in various oolong teas (Compounds
7e12).
Fig. 5 e Modeling of growth hormone-releasing hexapeptide-6 (GHRP-6) (AeD) and teaghrelins (EeH) binding to the ghrelin
receptor. (A) Modeling is displayed for the receptor (ribbon structure) with bound GHRP-6 (ball-stick structure). The binding
pocket of receptor is shown as spherical surface representation. (B) Enlarged diagram is depicted without the membrane
bilayer shown in the box of (A). (C, E, G) Amino acid residues around the binding pocket of the receptor are shown in stick
structure, and ligand compounds (GHRP-6, teaghrelin-1, and teaghrelin-2) in ball-stick structure. (D, F, H) Detailed
intermolecular interactions are illustrated between the receptor and ligands (GHRP-6, teaghrelin-1, and teaghrelin-2). The
amino acids of the receptor involved in the formation of H-bonding, cation-p interaction and charge-charge interaction are
shown in green, blue, and red squares, respectively. The H-bonding, cation-p interaction, and charge-charge interaction are
shown by green dash, blue dot, and red line, respectively.
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Fig. 6 e Modeling of Compounds 1e6 (Tea 1 to Tea 6) docking to the ghrelin receptor. (AeD) Modeling is displayed for
Compounds 1e4 (ball-stick structure) docking to the receptor (stick structure). The hydrophobic amino acids close to
glycosides of Compounds 1e4 are shown in grey ball-stick style and indicated by grey boxes. (E, G) Amino acid residues
around the binding pocket of the receptor are shown in stick structure, and ligands (Compounds 5 and 6) in ball-stick
structure. (F, H) Detailed intermolecular interactions are illustrated between the receptor and ligands. The amino acids of the
receptor involved in the formation of H-bonding and cation-p interaction are shown in green and blue squares, respectively.
The H-bonding and cation-p interaction are shown by green dash and blue dot, respectively.
Fig. 7 e Modeling of Compounds 9-12 (Tea 9 to Tea 12) docking to the ghrelin receptor. (A, C, E, G) Amino acid residues
around the binding pocket of the receptor are shown in stick structure, and ligands (Compounds 9e12) in ball-stick
structure. (B, D, F, H) Detailed intermolecular interactions are illustrated between the receptor and ligands. The amino acids
of the receptor involved in the formation of H-bonding and cation-p/p-p interactions are shown in green and blue squares,
respectively. The H-bonding and cation-p/p-p interactions are shown by green dash and blue dot, respectively.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 6 6 0e6 7 0668expected, GHRP-6 interacted strongly with the binding pocket
of the ghrelin receptor, and three types of intermolecular in-
teractions, including H-bonding, cation-p, and charge-charge
interaction, were observed between GHRP-6 and the receptor
(Figure 5D). Seven H-bonds were formed within the binding
pocket; two between the ammonium group of GHRP-6 and
E124 of the receptor, one between the ammonium group and
Y313, one between amine group at 6-backbone and P177, one
between carbonyl group at 6-backbone andQ120, one between
carbonyl group at 4-backbone and S207, and one between
amine group at 1-backbone and Q120. Two cation-p in-
teractions were formed; one between the ammoniumgroup of
GHRP-6 and W276 of the receptor, and the other between
phenylalanyl group of GHRP-6 and R283 of the receptor. One
salt bridgewas formed between nitrogen at 6-lysine of GHRP-6
and E124 of the receptor.
Similar to GHRP-6, both teaghrelin-1 (Compound 7) and
teaghrelin-2 (Compound 8) were able to interact adequately
with the binding pocket of the ghrelin receptor; however, only
one type of intermolecular interaction, H-bonding, was
observed in their interactions (Figures 5Ee5H). Seven H-bonds
were formed between teaghrelin-1 and the ghrelin receptor;
four between glycosides of teaghrelin-1and Q302/R107/W104
of the receptor, two between the C-400 hydroxyl group and
V212/R283, and one between C-7 hydroxyl group and E124
(Figure 5F). Comparably, there were also seven H-bonds
formed between teaghrelin-2 and the ghrelin receptor; three
between glycosides of teaghrelin-2 and E197/R199 of the re-
ceptor, two between the C-400 hydroxyl group and V212/R283,
one between C-7 hydroxyl group and E124, and one between
C-4 carbonyl group and Q120 (Figure 5H).4. Docking of biosynthetic intermediates of
teaghrelins into the ghrelin receptor
Among the six putative biosynthetic intermediates of teagh-
relins, Compounds 1e4 are only composed of flavonoid and
glycoside moieties whereas Compounds 5 and 6 contained an
extra coumaroyl group. Docking simulation showed that the
hydrophilic glycoside moieties of Compounds 1e4 were close
to five to 10 hydrophobic residues of the ghrelin receptor
(distances < 5 A˚) (Figures 6Ae6D). Apparently, only one hy-
drophobic moiety, flavonoid, in the structures of Compounds
1e4 was not sufficient to interact with the hydrophobic resi-
dues in the binding pocket of the ghrelin receptor, and the
hydrophilic-hydrophobic repulsions between glycosides of
Compounds 1e4 and the hydrophobic binding pocket of the
receptor significantly reduced the stability of the docking
complexes.
In contrast, flavonoid and the coumaroyl group of Com-
pounds 5 and 6 could interact adequately with the hydro-
phobic binding pocket of the ghrelin receptor in a manner
similar to teaghrelins (Figures 6Ee6H). In addition to a cation-
p interaction formed between the coumaroyl group of Com-
pound 5 and R283 of the ghrelin receptor, five H-bonds were
formed: three between the C-40 hydroxyl group of Compound
5 and S123/Y313 of the receptor, one between the C-7 hydroxyl
group and C198, and one between the C-400 hydroxyl group and
V212 (Figure 6F). Six H-bonds were formed betweenCompound 6 and the ghrelin receptor: four between glyco-
sides of Compound 6 and E197/R199 of the receptor, one be-
tween the C-7 hydroxyl group and Y313, and one between the
C-400 hydroxyl group and R283 (Figure 6H).
4.1. Docking of teaghrelin-like compounds into the
ghrelin receptor
Structurally, Compounds 9 and 10 are nearly identical to
teaghrelins except for the replacement of the last glucosewith
arabinose (R1 position in Figure 4). As expected, Compounds 9
and 10 interacted adequately with the binding pocket of the
ghrelin receptor (Figures 7Ae7D). In addition to cation-p and
p-p interactions formed between the coumaroyl group of
Compound 9 and R283/F279 of the ghrelin receptor, six H-
bonds were formed: two between the C-400 hydroxyl group of
Compound 9 and H280/R283 of the receptor, two between the
C-4 carbonyl group and S123/Y313, one between the C-7 hy-
droxyl group and E124, and two between glycosides and Q302/
N305 (Figure 7B). Eight H-bonds were formed between Com-
pound 10 and the ghrelin receptor: five between glycosides of
Compound 10 and E197/R199/T201/S207 of the receptor, two
between the C-400 hydroxyl group and S217/R283, and one
between the C-7 carbonyl group and S123 (Figure 7D).
In contrast, Compounds 11 and 12 failed to interact prop-
erly with the ghrelin receptor as the attachment of C-7
rhamnose hindered the entrance of flavonoid and the cou-
maroyl group into the binding pocket of the ghrelin receptor
(Figures 7Ee7H). Only two or three H-bonds were observed
between Compound 11 or 12 and the ghrelin receptor, and
thus the additional attachment of a rhamnosyl glycoside to
the flavonoid backbone of teaghrelin-like compounds at C-7
significantly reduced their binding affinity with the receptor.5. Discussion
In this study, we proposed that teaghrelin was converted from
rutin or nicotiflorin via three enzymatic steps according to the
identification of putative biosynthetic intermediates in Chin-
shin oolong tea. Molecular modeling and docking suggested
that only Compounds 5 and 6 possessing an additional p-
coumaric group were able to interact adequately with the
binding pocket of the ghrelin receptor among the six putative
biosynthetic intermediates. Moreover, four teaghrelin-like
compounds were identified in various oolong teas. Molecular
modeling and docking suggested that Compounds 9 and 10
possessing structures nearly identical to teaghrelins could
also interact adequately with the binding pocket of the ghrelin
receptor. In contrast, Compounds 11 and 12 possessing an
extra rhamnose directly linked to the flavonoid backbone at C-
7 failed to interact properly with the ghrelin receptor. There-
fore, it was suggested that the attachment of a coumaroyl
group was crucial for these tea compounds to bind to the
ghrelin receptor, but the additional attachment of a rhamno-
syl glycoside to the flavonoid backbone at C-7 significantly
reduced their binding affinity with the ghrelin receptor. Our
results suggest that Compounds 5, 6, 9, and 10 as well as
teaghrelins are adequate ligands of the ghrelin receptor, and
possess potential to be developed into oral ghrelin analogues.
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ghrelin analogues may be present in the rich sources of nat-
ural compounds from diverse herbal medicines. Indeed,
emoghrelin found in Heshouwuwas recently demonstrated to
be a promising agonist of the ghrelin receptor [33]. It is ex-
pected that more candidate compounds for ghrelin analogues
should be continually identified from natural sources.
Hydrophobic interaction between three nonpolar amino
acids (two tryptophan and one phenylalanine residues) of
GHRP-6 and the binding pocket of the ghrelin receptor plays
an important role in the stabilization of the binding complex.
Comparably, the nonpolar flavonoid and the coumaroyl group
of teaghrelins provide adequate molecular interaction with
the hydrophobic binding pocket of the ghrelin receptor. In
addition to the hydrophobic interaction, the positively
charged ammonium group of GHRP-6 provides a relatively
strong charge-charge interaction with a negative charge res-
idue (E124) in the binding pocket of the ghrelin receptor
(Figure 5D). This strong charge-charge interaction (salt bridge)
has been highlighted to play a critical role in the binding of
GHRP-6 to the ghrelin receptor [30]. However, the salt bridge
has no way to be formed in the docking simulation of teagh-
relins within the binding pocket of the ghrelin receptor due to
the lack of positively charged group in their structures. The
lack of strong charge-charge interaction presumably
explained why GHRP-6 possessed activity of growth hormone
secretion approximately 1000 times higher than teaghrelins as
observed previously [21].
Flavonoids, widely distributed in many plants, were found
to have several pharmacological activities, e.g. antiallergic,
anti-inflammatory, antioxidiant, antimicrobial activities, and
glycosylation and acylation of flavonoids resulted in huge di-
versity of flavonoid derivatives [34]. Flavonoid glycosides
acylated with certain hydroxycinnamic acid were recognized
for their physicochemical property of UV absorbing, and thus
accumulation of these flavonoid derivatives in plant tissues
was regarded as a protective solution against the damage of
UV radiation [35]. Possibly, the accumulation of teaghrelins in
Chin-shin oolong tea leaves is also related to the defensive
function of UV protection. It will be interesting to see if the
teaghrelin contents in the leaves of Chin-shin oolong tea
plants cultivated in various locations or harvested in different
seasons are affected by the availability of sunlight (UV radia-
tion) during their growth.
Acylation has been shown to modulate the physiological
activity of flavonoids by improving stability, enhancing bio-
logical effects and conferring novel bioactivities [36,37]. Pre-
sumably, acylation with p-coumaric acid found in the
structure of teaghrelins might play an important role in
mimicking ghrelin activity as well as enhancing structural
stability of these tea flavonoid derivatives during their meta-
bolism in animals as observed in our pervious study [21]. Being
a typical substrate constantly used for the study of flavonoid
acylation in vitro, rutin has been found to be acylated at the 3-
hydroxyl group of glucose and the 4-hydroxyl group of
rhamnose by bacterial enzymes [38]. However, the acylation
of p-coumaric acid in the structure of teaghrelins was un-
usually found at the 2-hydroxyl group of glucose on the rutin
or nicotiflorin moiety. Whether this unusual acylation in
teaghrelins is essential for their ghrelin-like activity andmetabolic stability in animals seems to be an important task
in the follow-up research.Conflicts of interest
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